Literature DB >> 22391777

Preneoplastic conditions underlying bile duct cancer.

Lena Sibulesky1, Justin Nguyen, Tushar Patel.   

Abstract

BACKGROUND: Malignancies arising from the biliary tract can arise from the epithelial lining of the biliary tract and surrounding tissues. Conditions that predispose to malignancy as well as preneoplastic changes in biliary tract epithelia have been identified. In this overview, we discuss preneoplastic conditions of the biliary tract and emphasize their clinical relevance.
RESULTS: Chronic biliary tract inflammation predisposes to cancer in the biliary tract. Biliary tract carcinogenesis involves a multistep process as a consequence of chronic biliary epithelial injury or inflammation. Reminiscent of other gastrointestinal epithelial malignancies such as gastric, colon, and pancreatic cancer, biliary tract cancers may evolve via multistep progression from epithelial hyperplasia and dysplasia to malignant transformation. The potential role of initiating cells is also becoming recognized.
CONCLUSIONS: In spite of improved risk factor recognition, and advances in diagnostic tools, the early diagnosis of pre-malignant or malignant biliary tract conditions is extremely challenging, and there is a paucity of evidence on which to base their management. As a result, the role of pre-emptive surgery remains largely undefined.

Entities:  

Mesh:

Year:  2012        PMID: 22391777      PMCID: PMC3804833          DOI: 10.1007/s00423-012-0943-7

Source DB:  PubMed          Journal:  Langenbecks Arch Surg        ISSN: 1435-2443            Impact factor:   3.445


  78 in total

Review 1.  Liver transplantation for cholangiocarcinoma.

Authors:  Charles B Rosen; Julie K Heimbach; Gregory J Gores
Journal:  Transpl Int       Date:  2010-05-20       Impact factor: 3.782

Review 2.  Infections and cancer: established associations and new hypotheses.

Authors:  Catherine de Martel; Silvia Franceschi
Journal:  Crit Rev Oncol Hematol       Date:  2008-09-20       Impact factor: 6.312

3.  Cholangiocarcinoma in primary sclerosing cholangitis: risk factors and clinical presentation.

Authors:  K M Boberg; A Bergquist; S Mitchell; A Pares; F Rosina; U Broomé; R Chapman; O Fausa; T Egeland; G Rocca; E Schrumpf
Journal:  Scand J Gastroenterol       Date:  2002-10       Impact factor: 2.423

Review 4.  Hepatolithiasis and the syndrome of recurrent pyogenic cholangitis: clinical, radiologic, and pathologic features.

Authors:  Wilson Man-shan Tsui; Yiu-kay Chan; Chi-tat Wong; Yan-fai Lo; Yat-wah Yeung; Yat-wing Lee
Journal:  Semin Liver Dis       Date:  2011-02-22       Impact factor: 6.115

5.  Extensive biliary intraepithelial neoplasia (BilIN) and multifocal early intrahepatic cholangiocarcinoma in non-biliary cirrhosis.

Authors:  Anne-Laure Rougemont; Muriel Genevay; Thomas A McKee; Magali Gremaud; Gilles Mentha; Laura Rubbia-Brandt
Journal:  Virchows Arch       Date:  2010-04-29       Impact factor: 4.064

6.  Diabetes mellitus and increased risk of cholangiocarcinoma: a meta-analysis.

Authors:  Wei Jing; Gang Jin; Xuyu Zhou; Yingqi Zhou; Yijie Zhang; Chenghao Shao; Rui Liu; Xiangui Hu
Journal:  Eur J Cancer Prev       Date:  2012-01       Impact factor: 2.497

7.  Hepatic and extrahepatic malignancies in primary sclerosing cholangitis.

Authors:  Annika Bergquist; Anders Ekbom; Rolf Olsson; Dan Kornfeldt; Lars Lööf; Ake Danielsson; Rolf Hultcrantz; Stefan Lindgren; Hanne Prytz; Hanna Sandberg-Gertzén; Sven Almer; Fredrik Granath; Ulrika Broomé
Journal:  J Hepatol       Date:  2002-03       Impact factor: 25.083

8.  Risk of hepatobiliary and pancreatic cancers after hepatitis C virus infection: A population-based study of U.S. veterans.

Authors:  Hashem B El-Serag; Eric A Engels; Ola Landgren; Elizabeth Chiao; Louise Henderson; Harshinie C Amaratunge; Thomas P Giordano
Journal:  Hepatology       Date:  2009-01       Impact factor: 17.425

9.  Survival and risk of cholangiocarcinoma in patients with primary sclerosing cholangitis. A population-based study.

Authors:  D Kornfeld; A Ekbom; T Ihre
Journal:  Scand J Gastroenterol       Date:  1997-10       Impact factor: 2.423

10.  Long-term outcome of liver transplantation in patients with PSC: a comparative analysis with PBC.

Authors:  Anurag Maheshwari; Hwan Y Yoo; Paul J Thuluvath
Journal:  Am J Gastroenterol       Date:  2004-03       Impact factor: 10.864

View more
  4 in total

1.  The risk factors and diagnosis of cholangiocarcinoma.

Authors:  Christopher A Wadsworth; Adrian Lim; Simon D Taylor-Robinson; Shahid A Khan
Journal:  Hepatol Int       Date:  2012-11-10       Impact factor: 6.047

2.  Imaging Monitoring of Kupffer Cell Function and Hepatic Oxygen Saturation in Preneoplastic Changes During Cholangiocarcinogenesis.

Authors:  Seunghyun Lee; Jung Hoon Kim; Jeong Hwa Lee; Yoh Zen; Joon Koo Han
Journal:  Sci Rep       Date:  2017-10-27       Impact factor: 4.379

3.  DNA Methylation Markers Improve the Sensitivity of Endoscopic Retrograde Cholangiopancreatography-Based Brushing Cytology in Extrahepatic Cholangiocarcinoma.

Authors:  Varayu Prachayakul; Jiraporn Kanchanapermpoon; Chanitra Thuwajit; Thiraphon Boonyaarunnate; Ananya Pongpaibul; Pornpimol Chobson; Peti Thuwajit
Journal:  Technol Cancer Res Treat       Date:  2017-12

4.  Long-term Proton Pump Inhibitor Administration Caused Physiological and Microbiota Changes in Rats.

Authors:  Yu-Chen S H Yang; Hsuen-Wen Chang; I-Hsuan Lin; Li-Nien Chien; Min-Ju Wu; Yun-Ru Liu; Peiguo G Chu; Guoxiang Xie; Fangcong Dong; Wei Jia; Vincent H S Chang; Yun Yen
Journal:  Sci Rep       Date:  2020-01-21       Impact factor: 4.379

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.